Email alerts
Advanced Search
  • Dec 3, 2012
    Medtronic Sentrino® CGM System Gains CE Mark
    System Designed to Improve Glucose Control in Critical Care Patients

    MINNEAPOLIS - December 3, 2012 - Medtronic, Inc. (NYSE:MDT) today announced CE (Conformité Européenne) Mark approval of its innovative Sentrino® Continuous Glucose Management System, the first...

  • Nov 26, 2012
    Medtronic EVP & President Mike Coyle to Speak at Piper Jaffray Healthcare Conference

    MINNEAPOLIS - Nov 26, 2012 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Piper Jaffray Healthcare Conference on...

  • Nov 20, 2012
    Medtronic Reports Second Quarter Earnings
    Revenue of $4.1 Billion Grew 5% on a Constant Currency Basis; 2% as Reported

    MINNEAPOLIS - November 20, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2013, which ended October 26, 2012. The Company reported...

  • Nov 13, 2012
    FDA Approves Medtronic Stent Graft for Aortic Transection Repair
    New Indication Expands Labeled Uses for Valiant® Captivia® System in U.S.; Six-Month Results of RESCUE Trial Will Be Presented at VEITHsymposium

    MINNEAPOLIS -- Nov. 13, 2012 -- Consistent with its commitment to clinical excellence, Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the...

  • Nov 13, 2012
    Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2013

    MINNEAPOLIS - Nov. 13, 2012 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2013 on Tuesday, November 20, 2012. A news...

Show 5102550100 per page